Product Information
CEFPROZIL 125 MG/5 ML SUSP is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1421 per ML under NDC 65862009901. Its NADAC has been published 613 times since Nov 28, 2013.
FDA first approved this application on Jan 30, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
125 mg/5mL
Manufacturer
Aurobindo Pharma LimitedNDC
65862009901
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
8/20/2025
Active Ingredients
CEFPROZILApproval Type
Generic (ANDA)
FDA Application
ANDA065381FDA Approved
1/30/2007
TE Code
AB
On Market Since
1/30/2007
Price Statistics
The NADAC for CEFPROZIL 125 MG/5 ML SUSP has been published 613 times since Nov 28, 2013, and over the history we have for it it has declined 54.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1421 per ML |
|---|---|
| All-time high | $0.3098 (Dec 11, 2013) |
| All-time low | $0.0917 (Jan 18, 2023) |
| Median price | $0.1944 |
| Average price | $0.2047 |
| Largest weekly change | +73.0% (May 18, 2022) |
| Weeks tracked | 613 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-3.2%
5Y
-24.0%
All
-54.2%
Last surveyed Aug 20, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 34% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFPROZIL 125 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 125 MG/5 ML SUSP, manufactured by Aurobindo Pharma Limited, is $0.1421 per ML (NDC 65862009901), effective Aug 20, 2025.
How has the price of CEFPROZIL 125 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has declined 54.2%. It has been tracked across 613 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFPROZIL 125 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for CEFPROZIL 125 MG/5 ML SUSP has ranged from a low of $0.0917 (Jan 18, 2023) to a high of $0.3098 (Dec 11, 2013), with a median of $0.1944 per ML.
Are there cheaper alternatives to CEFPROZIL 125 MG/5 ML SUSP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CEFPROZIL 125 MG/5 ML SUSP, is $0.0943 per ML — about 34% below CEFPROZIL 125 MG/5 ML SUSP.
Who manufactures CEFPROZIL 125 MG/5 ML SUSP?
CEFPROZIL 125 MG/5 ML SUSP (NDC 65862009901) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.